|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Imaging |
Departments of Radiological Sciences (W.E.R., J.O.G., J.W.L., L.E.K.), Behavioral Medicine (S.L.P., R.K.M.), Biostatistics (S.W., X.X.), and Hematology-Oncology (A.G.), St. Jude Children's Research Hospital, Memphis, TN 38105; Departments of Electrical and Computer Engineering (W.E.R.) and Biomedical Engineering (W.E.R.), University of Memphis, Memphis, TN 38152; USA
2 Address correspondence to Wilburn E. Reddick, Department of Radiological Sciences (MS #212), St. Jude Children's Research Hospital, 332 N. Lauderdale St., Memphis, TN 38105-2794, USA (gene.reddick{at}stjude.org).
Abstract
Most children with medulloblastoma (MB), the second most common pediatric brain tumor, have a 70% probability of survival. However, survivors who receive aggressive therapy are at significant risk of cognitive deficits that have been associated with lower volumes of normalappearing white matter (NAWM). We hypothesized that cranial irradiation inhibited normal brain volume development in these survivors. We retrospectively analyzed 324 MRI studies of 52 patients with histologically proven MB treated with surgery and 35 to 40 Gy craniospinal irradiation, with or without chemotherapy. The volume of NAWM and that of cerebrospinal fluid were quantified from a single index section and compared with those of healthy, age-similar control subjects. A quadratic random coefficient model was used to identify trends in brain volume with increasing age. Patients treated for MB at younger ages demonstrated substantially less development of NAWM volume than did their healthy peers. Younger age at the time of irradiation and the need for a ventricular shunt were significantly associated with reduced NAWM volume. NAWM and craniospinal fluid volume differences between patients who had shunts and those without resolved over a period of four to five years. NAWM volume is known to be associated with neurocognitive test performance, which shows deficiencies after cranial irradiation early in life. Therefore, volumetric monitoring of brain development can be used to guide the care of survivors, assess the toxicity of previous and current clinical trials, and aid in the design of therapies that minimize toxicity.
References
Andreasen, N.C., Flaum, M., Swayze, V., II., O'Leary, D.S.,
Alliger, R., Cohen, G., Ehrhardt, J., and Yuh, W.T.C. (1993)
Intelligence and brain structure in normal individuals. Am. J.
Psychiatry 150,130
-134.
Butler, R.W., and Copeland, D.R. (2002) Attentional processes and their remediation in children treated for cancer: A literature review and the development of a therapeutic approach. J. Int. Neuropsychol. Soc. 8,115 -124.[CrossRef][ISI][Medline]
Castellanos, F.X., Lee, P.P., Sharp, W., Jeffries, N.O.,
Greenstein, D.K., Clasen, L.S., Blumenthal, J.D., James, R.S., Ebens, C.L.,
Walter, J.M., Zijdenbos, A., Evans, A.C., Giedd, J.N., and Rapoport, J.L.
(2002) Developmental trajectories of brain volume abnormalities
in children and adolescents with attention-deficit/hyperactivity disorder.
JAMA 288,1740
-1748.
Dennis, M., Spiegler, B.J., Hetherington, C.R., and Greenberg, M.L. (1996) Neuropsychological sequelae of the treatment of children with medulloblastoma. J. Neurooncol. 29, 91-101.[CrossRef][Medline]
Giedd, J.N., Blumenthal, J., Jeffries, N.O., Castellanos, F.X., Liu, H., Zijdenbos, A., Paus, T., Evans, A.C., and Rapoport, J.L. (1999) Brain development during childhood and adolescence: A longitudinal MRI study. Nat. Neurosci. 2, 861-863.[CrossRef][ISI][Medline]
Glass, J.O., Ji, Q., Glas, L.S., and Reddick, W.E. (2003) Prediction of total cerebral tissue volumes in normal appearing brain from sub-sampled segmentation volumes. Magn. Reson. Imaging 21,977 -982.[CrossRef][ISI][Medline]
Inzitari, D. (2000) Age-related white matter changes and cognitive impairment. Ann. Neurol. 47,141 -143.[CrossRef][ISI][Medline]
Littell, R.C., Milliken, G.A., Stroup, W.S., and Wolfinger, R.D. (1996) SAS System for Mixed Models, Cary, N.C.: SAS Institute Inc.
Mulhern, R.K., Kepner, J.L., Thomas, P.R., Armstrong, F.D., Friedman, H.S., and Kun, L.E. (1998) Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group study. J. Clin. Oncol. 16,1723 -1728.[Abstract]
Mulhern, R.K., Reddick, W.E., Palmer, S.L., Glass, J.O., Elkin, T.D., Kun, L.E., Taylor, J.S., Langston, J.W., and Gajjar, A. (1999) Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann. Neurol. 46,834 -841.[CrossRef][ISI][Medline]
Mulhern, R.K., Palmer, S.L., Reddick, W.E., Glass, J.O., Kun, L.E.,
Taylor, J.S., Langston, J.A., and Gajjar, A. (2001) Risks of
young age for selected neurocognitive deficits in medulloblastoma are
associated with white matter loss. J. Clin. Oncol.
19,472
-479.
Palmer, S.L., Goloubeva, O., Reddick, W.E., Glass, J.O., Gajjar,
A., Kun, L.E., Merchant, T.E., and Mulhern, R.K. (2001) Patterns
of intellectual development among survivors of pediatric medulloblastoma: A
longitudinal analysis. J. Clin. Oncol.
19,2302
-2308.
Palmer, S.L., Gajjar, A., Reddick, W.E., Glass, J.O., Kun, L.E., Wu, S., Xiong, X., and Mulhern, R.K. (2003) Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma. Neuropsychology 17,548 -555.[CrossRef][ISI][Medline]
Reddick, W.E., Glass, J.O., Cook, E.N., Elkin, T.D., and Deaton, R.J. (1997) Automated segmentation and classification of multispectral magnetic resonance images of brain using artificial neural networks. IEEE Trans. Med. Imaging 16,911 -918.[CrossRef][ISI][Medline]
Reddick, W.E., Mulhern, R.K., Elkin, T.D., Glass, J.O., Merchant, T.E., and Langston, J.W. (1998) A hybrid neural network analysis of subtle brain volume differences in children surviving brain tumors. Magn. Reson. Imaging 16,413 -421.[CrossRef][ISI][Medline]
Reddick, W.E., Russell, J.M., Glass, J.O., Xiong, X., Mulhern, R.K., Langston, J.W., Merchant, T.E., Kun, L.E., and Gajjar, A. (2000) Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation. Magn. Reson. Imaging 18,787 -793.[CrossRef][ISI][Medline]
Reddick, W.E., Glass, J.O., Langston, J.W., and Helton, K.J. (2002) Quantitative MRI assessment of leukoencephalopathy. Magn. Reson. Med. 47,912 -920.[CrossRef][ISI][Medline]
Reddick, W.E., White, H.A., Glass, J.O., Wheeler, G.C., Thompson, S.J., Gajjar, A., Leigh, L., and Mulhern, R.K. (2003) Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors. Cancer 97,2512 -2519.[CrossRef][ISI][Medline]
Reiss, A.L., Abrams, M.T., Singer, H.S., Ross, J.L., and Denckla,
M.B. (1996) Brain development, gender and IQ in children. A
volumetric imaging study. Brain
119,1763
-1774.
Ris, M.D., Packer, R., Goldwein, J., Jones-Wallace, D., and Boyett,
J.M. (2001) Intellectual outcome after reduced-dose radiation
therapy plus adjuvant chemotherapy for medulloblastoma: A Children's Cancer
Group study. J. Clin. Oncol.
19,3470
-3476.
Schatz, J., Kramer, J.H., Ablin, A., and Matthay, K.K. (2000) Processing speed, working memory, and IQ: A developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology 14,189 -200.[CrossRef][ISI][Medline]
Sowell, E.R., Trauner, D.A., Gamst, A., and Jernigan, T.L. (2002) Development of cortical and subcortical brain structures in childhood and adolescence: A structural MRI study. Dev. Med. Child Neurol. 44,4 -16.[CrossRef][ISI][Medline]
Thompson, S.J., Leigh, L., Christensen, R., Xiong, X., Kun, L.E.,
Heideman, R.L., Reddick, W.E., Gajjar, A., Merchant, T., Pui, C.H., Hudson,
M.M., and Mulhern, R.K. (2001) Immediate neurocognitive effects
of methylphenidate on learning-impaired survivors of childhood cancer.
J. Clin. Oncol. 19,1802
-1808.
Zeltzer, P.M., Boyett, J.M., Finlay, J.L., Albright, A.L., Rorke,
L.B., Milstein, J.M., Allen, J.C., Stevens, K.R., Stanley, P., Li, H., Wisoff,
J.H., Geyer, J.R., McGuire-Cullen, P., Stehbens, J.A., Shurin, S.B., and
Packer, R.J. (1999) Metastasis stage, adjuvant treatment, and
residual tumor are prognostic factors for medulloblastoma in children:
Conclusions from the Children's Cancer Group 921 randomized phase III study.
J. Clin. Oncol. 17,832
-845.
This article has been cited by other articles:
|
|
 |
|
  S. L. Palmer, W. E. Reddick, and A. Gajjar Understanding the Cognitive Impact on Children Who are Treated for Medulloblastoma J. Pediatr. Psychol., October 1, 2007; 32(9): 1040 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Daly and R. T. Brown Scholarly Literature Review: Management of Neurocognitive Late Effects with Stimulant Medication J. Pediatr. Psychol., October 1, 2007; 32(9): 1111 - 1126. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
